Building upon its investments in developing healthier lighting solutions, Korrus has announced the recent acquisition of Circadian ZircLight Inc. Already building upon Korrus’s ecosystem of lighting focusing on human health and wellbeing, the addition of Circadian ZircLight also includes the addition of CEO Dr. Martin Moore-Ede as Korrus’s Chief Medical Advisor.
“In alignment with our mission to innovate, and provide the world with better, healthier light, the addition of Circadian ZircLight is a strong fit,” said Mark Reynoso, CEO of Korrus. “As our Chief Medical Advisor, Dr. Moore-Ede will continue in his work to publicly evangelize the values of healthy lighting and aid in our ongoing effort to develop health-optimized products across a wide range of applications.”
Korrus Welcomes Dr. Martin Moore-Ede as Chief Medical Advisor
Dr. Moore-Ede brings over 40 years of expertise in the fields of circadian biology and light study to the position, having been a professor at Harvard Medical School (1975 – 1998) leading the team that ultimately discovered the main governing body for the circadian cycle within the brain. During his time at the university, he also pioneered research on how the human body can safely adapt to working outside of regular circadian parameters.
In 1983, Dr. Moore-Ede founded the global consulting and technology firm, CIRCADIAN, which helps industries operating on 24/7 workforce schedule optimize productivity, health and safety. In 2011, Dr. Moore-Ede formed Circadian ZircLight in response to growing client concerns over the harmful effects of conventional lighting and the health, safety and performance of their workers.
The addition of Circadian ZircLight, and Dr. Moore-Ede, long-time advocate for the role of light in circadian health, as Chief Medical Advisor, further positions Korrus as a trailblazer in the human-centric lighting industry.
“I am excited to be joining Korrus at this pivotal moment in the history of light as we harness the power of digital light to optimize health, wellbeing, and human performance,” said Dr. Moore-Ede. “It is now possible to spectrally engineer light to reduce the risk of numerous diseases caused by circadian disruption, including diabetes, heart disease and cancer.”
